News & Updates

Use of high-dose oxytocin postpartum appears to result in reduced rates of postpartum haemorrhage (PPH) when compared with traditional doses, as shown in a study presented at SMFM 2024.

The long-acting combination of cabotegravir plus rilpivirine, administered as monthly or once-every-2-months jabs, appears to be effective in both older and younger patients living with HIV, with most maintaining virologic suppression through week 96, according to pooled data from the phase III ATLAS, FLAIR, and ATLAS-2M studies.